Suvretta Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-951,986
| Closed | -$63.9M | – | 92 |
|
|
2022
Q2 | $63.9M | Buy |
951,986
+441,655
| +87% | +$29.6M | 2.43% | 17 |
|
|
2022
Q1 | $42M | Buy |
510,331
+107,542
| +27% | +$8.84M | 1.28% | 31 |
|
|
2021
Q4 | $59.1M | Buy |
402,789
+211,481
| +111% | +$31M | 1.14% | 31 |
|
|
2021
Q3 | $33.8M | Buy |
191,308
+42,436
| +29% | +$7.51M | 0.57% | 40 |
|
|
2021
Q2 | $24M | Buy |
+148,872
| New | +$24M | 0.36% | 55 |
|